Physician profile
Fernando S Aran
NPI 1235516907
$23,870.68
in general payments reported to CMS, 2019-2025
21 companies · $8,319 in 2025
The $8,319 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,429 · 2022: $8,653 · 2023: $3,433 · 2024: $1,037 · 2025: $8,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,544 · Food and Beverage: $5,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,543.54 |
| Food and Beverage | $5,245.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $14,583.84 | 2021-2025 | Implate, Geminus, Ijs |
| Smith+Nephew, INC. | $2,447.27 | 2021-2025 | Journey II, Real Intelligence, Legion Revision |
| Southern Edge Orthopaedics, INC. | $1,498.83 | 2022-2023 | |
| Southtech Orthopedics | $1,200.00 | 2021 | |
| Arthrex, INC. | $1,117.37 | 2021-2023 | |
| Stryker Corporation | $888.93 | 2021-2025 | Infinity Adaptis, Inbone, Augment Injectable |
| Treace Medical Concepts, INC. | $612.84 | 2022-2025 | |
| Depuy Synthes Sales INC. | $364.26 | 2022-2025 | Tfn-Advance, Truespan Orthocord, Orthovisc |
| Miach Orthopaedics, INC. | $184.62 | 2023 | |
| Biocomposites INC | $144.08 | 2022 | |
| Bioventus LLC | $142.55 | 2021-2025 | Exogen Ultrasound Bone Healing System, Xcell |
| Medshape, INC. | $140.59 | 2021 | |
| Paragon 28, INC. | $127.55 | 2024 | Additive Orthopedics |
| Exactech, INC. | $112.77 | 2022 | |
| Amgen INC. | $90.92 | 2024-2025 | Krystexxa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $65.20 | 2024 | |
| Ermi LLC | $51.03 | 2025 | |
| Embody, INC. | $25.60 | 2021 | |
| Horizon Therapeutics Plc | $25.44 | 2023 | Krystexxa |
| Djo, LLC | $23.63 | 2025 | Cmf |
| Abbott Laboratories | $23.36 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Aran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.